{"id":"https://openalex.org/W7224097474","doi":"https://doi.org/10.1002/jca.70199","title":"The Place of Therapeutic Apheresis in Severe Immune\u2010Related Adverse Events: A Scoping Review of Literature","display_name":"The Place of Therapeutic Apheresis in Severe Immune\u2010Related Adverse Events: A Scoping Review of Literature","publication_year":2026,"publication_date":"2026-10-28","ids":{"openalex":"https://openalex.org/W7224097474","doi":"https://doi.org/10.1002/jca.70199","pmid":"https://pubmed.ncbi.nlm.nih.gov/42951701","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13716841"},"language":"en","primary_location":{"id":"doi:10.1002/jca.70199","doi":"https://doi.org/10.1002/jca.70199","is_oa":true,"landing_page_url":"https://doi.org/10.1002/jca.70199","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jca.70199","source":{"id":"https://openalex.org/S189671064","display_name":"Journal of Clinical Apheresis","issn_l":"0733-2459","issn":["0733-2459","1098-1101"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Apheresis","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jca.70199","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5015451530","display_name":"C Vuillet","orcid":"https://orcid.org/0009-0008-7922-2883","observed_orcids":["https://orcid.org/0009-0008-7922-2883"]},"institutions":[{"id":"https://openalex.org/I4210093292","display_name":"Centre Hospitalier Universitaire de Montpellier","ror":"https://ror.org/00mthsf17","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210093292"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"C. Vuillet","raw_affiliation_strings":["Internal Medicine and Clinical Immunology Department Montpellier University Hospital  Montpellier France"],"raw_orcid":"https://orcid.org/0009-0008-7922-2883","affiliations":[{"raw_affiliation_string":"Internal Medicine and Clinical Immunology Department Montpellier University Hospital  Montpellier France","institution_ids":["https://openalex.org/I4210093292"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087896662","display_name":"Olivier P. Moranne","orcid":"https://orcid.org/0000-0002-3127-1415","observed_orcids":["https://orcid.org/0000-0002-3127-1415"]},"institutions":[{"id":"https://openalex.org/I4210104607","display_name":"Centre Hospitalier Universitaire de N\u00eemes","ror":"https://ror.org/0275ye937","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210104607"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"O. Moranne","raw_affiliation_strings":["Nephrology, Dialysis, Apheresis Department IDESP Montpellier University, N\u00eemes University Hospital  N\u00eemes France"],"raw_orcid":"https://orcid.org/0000-0002-3127-1415","affiliations":[{"raw_affiliation_string":"Nephrology, Dialysis, Apheresis Department IDESP Montpellier University, N\u00eemes University Hospital  N\u00eemes France","institution_ids":["https://openalex.org/I4210104607"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160054645","display_name":"D. Daubin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210093292","display_name":"Centre Hospitalier Universitaire de Montpellier","ror":"https://ror.org/00mthsf17","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210093292"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"D. Daubin","raw_affiliation_strings":["Intensive Care Unit Montpellier University Hospital  Montpellier France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Intensive Care Unit Montpellier University Hospital  Montpellier France","institution_ids":["https://openalex.org/I4210093292"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035680745","display_name":"Xavier Quantin","orcid":"https://orcid.org/0000-0002-5403-3612","observed_orcids":["https://orcid.org/0000-0002-5403-3612"]},"institutions":[{"id":"https://openalex.org/I4210140335","display_name":"Institut de Recherche en Canc\u00e9rologie de Montpellier","ror":"https://ror.org/03capj968","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I19894307","https://openalex.org/I4210140335","https://openalex.org/I4210141925","https://openalex.org/I4387154388"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"X. Quantin","raw_affiliation_strings":["Regional Institute of Cancer  Montpellier France"],"raw_orcid":"https://orcid.org/0000-0002-5403-3612","affiliations":[{"raw_affiliation_string":"Regional Institute of Cancer  Montpellier France","institution_ids":["https://openalex.org/I4210140335"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029038931","display_name":"Pascale Palassin","orcid":"https://orcid.org/0000-0003-2717-9437","observed_orcids":["https://orcid.org/0000-0003-2717-9437"]},"institutions":[{"id":"https://openalex.org/I4210093292","display_name":"Centre Hospitalier Universitaire de Montpellier","ror":"https://ror.org/00mthsf17","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210093292"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"P. Palassin","raw_affiliation_strings":["Medical Pharmacology and Toxicology Department Montpellier University Hospital  Montpellier France"],"raw_orcid":"https://orcid.org/0000-0003-2717-9437","affiliations":[{"raw_affiliation_string":"Medical Pharmacology and Toxicology Department Montpellier University Hospital  Montpellier France","institution_ids":["https://openalex.org/I4210093292"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037604880","display_name":"Tarik Kanouni","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210093292","display_name":"Centre Hospitalier Universitaire de Montpellier","ror":"https://ror.org/00mthsf17","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210093292"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"T. Kanouni","raw_affiliation_strings":["Hematology and Apheresis Department Montpellier University Hospital  Montpellier France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology and Apheresis Department Montpellier University Hospital  Montpellier France","institution_ids":["https://openalex.org/I4210093292"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069694454","display_name":"Alexandre Thibault Jacques Maria","orcid":"https://orcid.org/0000-0002-0868-5804","observed_orcids":["https://orcid.org/0000-0002-0868-5804"]},"institutions":[{"id":"https://openalex.org/I4210093292","display_name":"Centre Hospitalier Universitaire de Montpellier","ror":"https://ror.org/00mthsf17","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210093292"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"A. T. J. Maria","raw_affiliation_strings":["Internal Medicine and Clinical Immunology Department Montpellier University Hospital  Montpellier France"],"raw_orcid":"https://orcid.org/0000-0002-0868-5804","affiliations":[{"raw_affiliation_string":"Internal Medicine and Clinical Immunology Department Montpellier University Hospital  Montpellier France","institution_ids":["https://openalex.org/I4210093292"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5160049569","display_name":"the MonRIO network (Montpellier R\u00e9seau Immuno\u2010Oncologie)","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I19894307","display_name":"Universit\u00e9 de Montpellier","ror":"https://ror.org/051escj72","country_code":"FR","type":"education","lineage":["https://openalex.org/I19894307"]},{"id":"https://openalex.org/I4210095750","display_name":"Institute for Regenerative Medicine & Biotherapy","ror":"https://ror.org/00b8mh310","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I19894307","https://openalex.org/I4210095750"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"the MonRIO network (Montpellier R\u00e9seau Immuno\u2010Oncologie)","raw_affiliation_strings":["IHU Immun4Cure, IRMB, Inserm U1183, Montpellier University, Montpellier, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IHU Immun4Cure, IRMB, Inserm U1183, Montpellier University, Montpellier, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I19894307","https://openalex.org/I4210095750"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5015451530"],"corresponding_institution_ids":["https://openalex.org/I4210093292"],"apc_list":{"value":3920,"currency":"USD","value_usd":3920},"apc_paid":{"value":3920,"currency":"USD","value_usd":3920},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.60223748,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"41","issue":"6","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/therapeutic-apheresis","display_name":"therapeutic apheresis","score":0.9990000128746033},{"id":"https://openalex.org/keywords/immune-related-adverse-events","display_name":"immune-related adverse events","score":0.984000027179718},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.9990000128746033},{"id":"https://openalex.org/keywords/immunosuppression","display_name":"immunosuppression","score":0.574999988079071},{"id":"https://openalex.org/keywords/anti-pd-1-therapy","display_name":"anti-PD-1 therapy","score":0.7580000162124634},{"id":"https://openalex.org/keywords/hepatitis","display_name":"hepatitis","score":0.5139999985694885},{"id":"https://openalex.org/keywords/overlap-syndrome","display_name":"overlap syndrome","score":0.6320000290870667},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.8859999775886536},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.9980000257492065},{"id":"https://openalex.org/keywords/extracorporeal-blood-purification","display_name":"extracorporeal blood purification","score":0.6179999709129333}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9677000045776367},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.7544000148773193},{"id":"https://openalex.org/C2776738589","wikidata":"https://www.wikidata.org/wiki/Q618446","display_name":"Apheresis","level":3,"score":0.583899974822998},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.5702000260353088},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4909999966621399},{"id":"https://openalex.org/C2778384578","wikidata":"https://www.wikidata.org/wiki/Q16930687","display_name":"Therapeutic approach","level":3,"score":0.46650001406669617},{"id":"https://openalex.org/C2994232697","wikidata":"https://www.wikidata.org/wiki/Q1115882","display_name":"Extracorporeal circulation","level":2,"score":0.39640000462532043},{"id":"https://openalex.org/C2779915274","wikidata":"https://www.wikidata.org/wiki/Q1115882","display_name":"Extracorporeal","level":2,"score":0.3865000009536743},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.3637000024318695},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.3528999984264374},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.3483999967575073},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.3294999897480011},{"id":"https://openalex.org/C2776029263","wikidata":"https://www.wikidata.org/wiki/Q131742","display_name":"Hepatitis","level":2,"score":0.3068000078201294},{"id":"https://openalex.org/C102652120","wikidata":"https://www.wikidata.org/wiki/Q2419430","display_name":"Therapeutic effect","level":2,"score":0.2865000069141388},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.26750001311302185},{"id":"https://openalex.org/C2778842783","wikidata":"https://www.wikidata.org/wiki/Q603502","display_name":"Plasmapheresis","level":3,"score":0.26489999890327454},{"id":"https://openalex.org/C2779839709","wikidata":"https://www.wikidata.org/wiki/Q1660148","display_name":"Immunoadsorption","level":3,"score":0.2639000117778778},{"id":"https://openalex.org/C2910749824","wikidata":"https://www.wikidata.org/wiki/Q603502","display_name":"Therapeutic plasma exchange","level":2,"score":0.2624000012874603}],"mesh":[{"descriptor_ui":"D000082082","descriptor_name":"Immune Checkpoint Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D001327","descriptor_name":"Autoimmune Diseases","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D001781","descriptor_name":"Blood Component Removal","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1002/jca.70199","doi":"https://doi.org/10.1002/jca.70199","is_oa":true,"landing_page_url":"https://doi.org/10.1002/jca.70199","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jca.70199","source":{"id":"https://openalex.org/S189671064","display_name":"Journal of Clinical Apheresis","issn_l":"0733-2459","issn":["0733-2459","1098-1101"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Apheresis","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13716841","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13716841/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13716841/pdf/JCA-41-e70199.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Clin Apher","raw_type":"Text"},{"id":"pmid:42951701","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42951701","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical apheresis","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1002/jca.70199","doi":"https://doi.org/10.1002/jca.70199","is_oa":true,"landing_page_url":"https://doi.org/10.1002/jca.70199","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jca.70199","source":{"id":"https://openalex.org/S189671064","display_name":"Journal of Clinical Apheresis","issn_l":"0733-2459","issn":["0733-2459","1098-1101"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Apheresis","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Systematic Review","id":"https://openalex.org/study-designs/systematic-review"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7224097474.pdf","grobid_xml":"https://content.openalex.org/works/W7224097474.grobid-xml"},"referenced_works_count":42,"referenced_works":["https://openalex.org/W1878044069","https://openalex.org/W2066671159","https://openalex.org/W2289841322","https://openalex.org/W2786816161","https://openalex.org/W2891486030","https://openalex.org/W2999281781","https://openalex.org/W3010839046","https://openalex.org/W3188008585","https://openalex.org/W4224280159","https://openalex.org/W4281648469","https://openalex.org/W4285023524","https://openalex.org/W4296462914","https://openalex.org/W4296629891","https://openalex.org/W4309998959","https://openalex.org/W4321181042","https://openalex.org/W4321458995","https://openalex.org/W4362602027","https://openalex.org/W4365483689","https://openalex.org/W4375950730","https://openalex.org/W4379600907","https://openalex.org/W4386392356","https://openalex.org/W4386830543","https://openalex.org/W4387166230","https://openalex.org/W4387670068","https://openalex.org/W4387736639","https://openalex.org/W4388672053","https://openalex.org/W4388795706","https://openalex.org/W4393155102","https://openalex.org/W4393992966","https://openalex.org/W4396580926","https://openalex.org/W4399700968","https://openalex.org/W4400315647","https://openalex.org/W4400760618","https://openalex.org/W4401059324","https://openalex.org/W4403695346","https://openalex.org/W4404242483","https://openalex.org/W4404968261","https://openalex.org/W4407202989","https://openalex.org/W4409653386","https://openalex.org/W4410185720","https://openalex.org/W4410217888","https://openalex.org/W4410355929"],"related_works":["https://openalex.org/W3015164332","https://openalex.org/W7117310466","https://openalex.org/W4294151509","https://openalex.org/W3090847458","https://openalex.org/W3111469203","https://openalex.org/W2982239768","https://openalex.org/W4310106152","https://openalex.org/W4391757110","https://openalex.org/W3014279612","https://openalex.org/W2982081566"],"abstract_inverted_index":{"Immune":[0],"checkpoint":[1],"inhibitors":[2],"(ICIs)":[3],"have":[4],"revolutionized":[5],"the":[6,90,111,116,262],"management":[7],"of":[8,92,113,118,170,206,209,212,226],"patients":[9,148,171],"with":[10,174,228,244,259],"cancer.":[11],"However,":[12,267],"they":[13],"can":[14,32],"induce":[15,241],"breakdowns":[16],"in":[17,78,115,133,199,220,261,284],"immunologic":[18],"tolerance,":[19],"leading":[20],"to":[21,87,101,279],"autoimmune":[22],"diseases,":[23],"or":[24,44,72,123],"immune":[25],"related":[26],"adverse":[27],"events":[28],"(irAEs).":[29],"These":[30],"irAEs":[31],"sometimes":[33],"be":[34,251],"life":[35,256],"threatening,":[36],"requiring":[37],"aggressive":[38],"management,":[39],"such":[40],"as":[41,283],"immunosuppressant":[42],"(IS)":[43],"even":[45],"therapeutic":[46,57,247,253],"apheresis":[47],"(TA).":[48],"TA,":[49,227],"an":[50],"extracorporeal":[51],"circulation":[52],"technique,":[53],"may":[54,250],"represent":[55],"a":[56,252],"option":[58,254],"for":[59,94,108,150,180,255],"severe":[60,96,151,242],"irAEs,":[61,243,258],"reducing":[62],"their":[63],"severity":[64],"and":[65,138,166,168,188,232],"duration":[66],"by":[67],"removing":[68],"ICIs,":[69],"pathogenic":[70],"antibodies":[71],"inflammatory":[73],"cytokines,":[74],"although":[75],"its":[76,265,270,281],"role":[77],"this":[79],"situation":[80],"remains":[81],"underreported.":[82],"We":[83],"made":[84],"scoping":[85],"review":[86],"better":[88],"identify":[89],"use":[91,112,271,282],"TA":[93,114,154,181,194,213,249],"managing":[95],"irAEs.":[97,285],"From":[98],"January":[99],"2022":[100,137],"August":[102],"2025,":[103,139],"three":[104],"databases":[105],"were":[106,126,142,155,160,172,182,214],"reviewed,":[107],"articles":[109,141,145],"mentioning":[110],"event":[117],"immunotoxicity.":[119],"Only":[120],"case":[121,124],"reports":[122],"series":[125],"retained.":[127],"A":[128],"descriptive":[129],"summary":[130],"was":[131,195,218],"produced":[132],"table":[134],"forms.":[135],"Between":[136],"162":[140],"identified,":[143],"34":[144],"concerning":[146],"42":[147],"treated":[149,173],"irAE":[152],"via":[153],"included.":[156],"The":[157,177],"underlying":[158],"cancers":[159],"mainly":[161,191],"non-small":[162],"cell":[163],"lung":[164],"cancer":[165,238],"melanoma,":[167],"78%":[169],"monotherapy":[175],"anti-PD(L)1.":[176],"main":[178],"indications":[179],"neurological":[183],"(40.6%),":[184],"overlap":[185],"manifestations":[186],"(23.8%),":[187],"hepatitis":[189],"(21.4%),":[190],"highly":[192],"severe.":[193],"most":[196,221],"often":[197],"used":[198],"rescue":[200],"situations,":[201],"that":[202],"is,":[203],"after":[204],"failure":[205],"several":[207],"lines":[208],"IS.":[210],"Complications":[211],"rare.":[215],"Clinical":[216],"improvement":[217],"reported":[219],"patients,":[222],"usually":[223],"within":[224],"days":[225],"24%":[229],"complete":[230],"resolution,":[231],"45%":[233],"partial":[234],"resolution.":[235],"Despite":[236],"revolutionizing":[237],"treatment,":[239],"ICIs":[240],"poorly":[245,273],"defined":[246],"options.":[248],"threatening":[257],"data":[260],"literature":[263],"assuming":[264],"effectiveness.":[266],"details":[268],"on":[269],"remain":[272],"defined.":[274],"Further":[275],"studies":[276],"are":[277],"required":[278],"emphasize":[280]},"counts_by_year":[],"updated_date":"2026-11-02T09:45:03.842371","created_date":"2026-10-29T00:00:00"}